Nuvation Bio Inc 研发费用 : $ 71.29 (2023年12月 TTM)
Nuvation Bio Inc研发费用(Research & Development)的相关内容及计算方法如下:
研发费用是公司在研发上花费的费用。
截至2023年12月, Nuvation Bio Inc 过去一季度 的 研发费用 为 $ 15.35。 Nuvation Bio Inc 最近12个月的 研发费用 为 $ 71.29。
点击上方“历史数据”快速查看Nuvation Bio Inc 研发费用的历史走势;
点击上方“解释说明”快速查看关于Nuvation Bio Inc 研发费用的详细说明;
点击上方“相关词条”快速查看与研发费用相关的其他指标。
Nuvation Bio Inc 研发费用 (NUVB.WS 研发费用) 历史数据
Nuvation Bio Inc 研发费用的历史年度,季度/半年度走势如下:
Nuvation Bio Inc 研发费用 年度数据 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
日期 | 2020-12 | 2021-12 | 2022-12 | 2023-12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
研发费用 | 32.60 | 69.04 | 87.82 | 71.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nuvation Bio Inc 研发费用 季度数据 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
日期 | 2021-09 | 2021-12 | 2022-03 | 2022-06 | 2022-09 | 2022-12 | 2023-03 | 2023-06 | 2023-09 | 2023-12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
研发费用 | 17.12 | 22.00 | 20.73 | 28.92 | 21.29 | 16.87 | 18.79 | 18.59 | 18.56 | 15.35 |
Nuvation Bio Inc 研发费用 (NUVB.WS 研发费用) 解释说明
研发费用是公司在研发上花费的费用。如果一个公司的竞争优势是通过专利或技术优势创造的,那么这个优势一般会在将在某个时候消失。
高额的研发费用通常意味着高的 销售及行政开支 。
Nuvation Bio Inc 研发费用 (NUVB.WS 研发费用) 相关词条
感谢查看价值大师中文站为您提供的Nuvation Bio Inc研发费用的详细介绍,请点击以下链接查看与Nuvation Bio Inc研发费用相关的其他词条:
Nuvation Bio Inc (NUVB.WS) 公司简介
一级行业:医疗保健
二级行业:生物科技
公司网站:https://www.nuvationbio.com
公司地址:1500 Broadway, Suite 1401, New York, NY, USA, 10036
公司简介:Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
二级行业:生物科技
公司网站:https://www.nuvationbio.com
公司地址:1500 Broadway, Suite 1401, New York, NY, USA, 10036
公司简介:Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).